Zevra Therapeutics, Inc. (ZVRA)

Zevra Therapeutics Market Cap

Zevra Therapeutics has a market cap or net worth of $195.42 million as of April 18, 2024. Its market cap has decreased by -6.81% in one year.

• Market Cap: 195.42M
• Enterprise Value: 171.45M
• 1-Year Change: -6.81%
• Ranking: #3630
• Category: Micro-Cap
• Stock Price: $4.50

Market Cap Chart

Since April 16, 2015, Zevra Therapeutics's market cap has increased from $137.80M to $195.42M, an increase of 41.81%. That is a compound annual growth rate of 3.95%.

Market Cap History

Date	Market Cap	% Change
Apr 18, 2024	195.40M	-3.03%
Apr 17, 2024	201.50M	-2.70%
Apr 16, 2024	207.10M	-0.34%
Apr 15, 2024	207.80M	-0.29%
Apr 12, 2024	208.40M	-2.84%
Apr 11, 2024	214.50M	0.37%
Apr 10, 2024	213.70M	4.04%
Apr 9, 2024	205.40M	-4.24%
Apr 8, 2024	214.50M	2.48%
Apr 5, 2024	209.30M	-1.83%
Apr 4, 2024	213.20M	-2.38%
Apr 3, 2024	218.40M	-1.67%
Apr 2, 2024	222.10M	-0.89%
Apr 1, 2024	224.10M	6.66%
Mar 28, 2024	210.10M	-2.32%
Mar 27, 2024	215.10M	3.81%
Mar 26, 2024	207.20M	1.42%
Mar 25, 2024	204.30M	-2.06%
Mar 22, 2024	208.60M	-1.37%
Mar 21, 2024	211.50M	-3.34%
Mar 20, 2024	218.80M	1.53%
Mar 19, 2024	215.50M	-0.19%
Mar 18, 2024	215.90M	-0.64%
Mar 15, 2024	217.30M	-2.42%
Mar 14, 2024	222.70M	-2.11%

View and export this data all the way back to 2015. Sign Up Today.

Related Stocks

Company	Market Cap
Actinium Pharmaceuticals	212.12M
Galectin Therapeutics	211.71M
Acumen Pharmaceuticals	209.68M
Innate Pharma	206.95M
X4 Pharmaceuticals	202.79M
Elevation Oncology	200.44M
Cardiff Oncology	200.15M
Lifecore Biomedical	199.17M